Characterization of extended-spectrum β-lactamases and integrons in Escherichia coli isolates in a Spanish hospital

Journal of Medical Microbiology

Volumn 57, Issue 7, 2008, Pages 916-920

  Vinuè, Laura ^a   Lantero, Marta ^b   Sáenz, Yolanda ^a   Somalo, Sergio ^a   De Diego, Isabel ^b   Pérez, Francisco ^b   Ruiz Larrea, Fernanda ^a   Zarazaga, Myriam ^a   Torres, Carmen ^a  

^a UNIVERSITY OF LA RIOJA   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE AMPC; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; FOSFOMYCIN; GENTAMICIN; IMIPENEM; NALIDIXIC ACID; TOBRAMYCIN; ANTIINFECTIVE AGENT; BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERIUM ISOLATE; ESCHERICHIA COLI; HOSPITAL; INTEGRON; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPAIN; DRUG EFFECT; ENTEROBACTER INFECTION; ENZYMOLOGY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PREVALENCE; STATISTICS;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEPHALOSPORIN RESISTANCE; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HOSPITALS; HUMANS; INTEGRONS; MICROBIAL SENSITIVITY TESTS; PREVALENCE; SPAIN;

EID: 48949104323     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.47723-0     Document Type: Letter

References (34)

1. Bertrand, S., Weill, F. X., Cloeckaert, A., Vrints, M., Mairiaux, E., Praud, K., Dierick, K., Wildemauve, C., Godard, C. & other authors (2006). Clonal emergence of extended-spectrum β-lactamase (CTX-M-2)-producing Salmonella enterica serovar Virchow isolates with reduced susceptibilities to ciprofloxacin among poultry and humans in Belgium and France (2000 to 2003). J Clin Microbiol 44, 2897-2903.
2. Bischoff, K. M., White, D. G., Hume, M. E., Poole, T. L. & Nisbet, D. J. (2005). The chloramphenicol resistance gene cmlA is disseminated on transferable plasmids that confer multiple-drug resistance in swine Escherichia coli. FEMS Microbiol Lett 243, 285-291.
3. Brasme, L., Nordmann, P., Fidel, F., Lartigue, M. F., Bajolet, O., Poirel, L., Forte, D., Vernet-Garnier, V., Madoux, J. & other authors (2007). Incidence of class A extended-spectrum β-lactamases in Champagne-Ardenne (France): a 1 year prospective study. J Antimicrob Chemother 60, 956-964.
4. Briñas, L., Lantero, M., Diego, I., Álvarez, M., Zarazaga, M. & Torres, C. (2005). Mechanisms of resistance to broad-spectrum-cephalosporins in Escherichia coli isolates recovered in a Spanish hospital. J Antimicrob Chemother 56, 1107-1110.
5. Cantón, R., Novais, A., Valverde, A., Machado, E., Peixe, L., Baquero, F. & Coque, T. M. (2008). Prevalence and spread of extended-spectrum β- lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 14, 144-153.
6. Caroff, N., Esparze, E., Gautreau, D., Richet, H. & Reynaud, A. (2000). Analysis of the effect of -42 and -32 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing AmpC. J Antimicrob Chemother 45, 783-788.
7. Cartelle, M., Tomas, M. M., Molina, F., Moure, R., Villanueva, R. & Bou, G. (2004). High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitution. Antimicrob Agents Chemother 48, 2308-2313.
8. Chang, C. Y., Chang, L. L., Chang, Y. H., Lee, T. M. & Chang, S. F. (2000). Characterisation of drug resistance gene cassettes associated with class 1 integrons in clinical isolates of Escherichia coli from Taiwan, ROC. J Med Microbiol 49, 1097-1102.
9. CLSI (2007). Performance Standards for Antimicrobial Susceptibility Testing; 17th informational supplement, M100-S17. Wayne. PA: Clinical and Laboratory Standards Institute.
10. Du, X., Shen, Z., Wu, B., Xia, S. & Shen, J. (2005). Characterization of class 1 integrons-mediated antibiotic resistance among calf pathogenic Escherichia coli. FEMS Microbiol Lett 245, 295-298.
11. Eckert, C., Gautier, V., Saladin-Allard, M., Hidri, N., Verdet, C., Ould-Hocine, Z., Barnaud, G., Delisle, F., Rossier, A. & other authors (2004). Dissemination of CTX-M-type β-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob Agents Chemother 48, 1249-1255.
12. CTX-M genes. J Antimicrob Chemother 57, 14-23.
13. Hernández, J. R., Martínez-Martínez, L., Cantón, R., Coque, T. M., Pascual, A. & the Spanish Group for Nosocomial Infections (GEIH) (2005). Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in Spain. Antimicrob Agents Chemother 49, 2122-2125.
14. Ho, P. L., Poon, W. W. N., Loke, S. L., Leung, M. S. T., Chow, K. H., Wong, R. C. W., Yip, K. S., Lai, E. L. & Tsang, K. W. T. on behalf of the COMBAT Study Group (2007). Community emergence of CTX-M type extended-spectrum β-lactamases among urinary Escherichia coli from women. J Antimicrob Chemother 60, 140-144.
15. Huletsky, A., Knox, J. R. & Levesque, R. C. (1993). Role of Ser-238 and Lys-240 in the hydrolysis of third-generation cephalosporins by SHV-type β-lactamases probed by site-directed mutagenesis and three-dimensional modeling. J Biol Chem 268, 3690-3697.
16. Jarlier, V., Nicola, M. H., Fournier, G. & Philippon, A. (1988). Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 10, 867-878.
17. Jouini, A., Vinué, L., Slama, K. B., Sáenz, Y., Klibi, N., Hammami, S., Boudabous, A. & Torres, C. (2007). Characterization of CTX-M and SHV extended-spectrum β-lactamases and associated resistance genes in Escherichia coli strains of food samples in Tunisia. J Antimicrob Chemother 60, 1137-1141.
18. CTX-M genes. FEMS Microbiol Lett 234, 201-207.
19. Morosini, M. I., García-Castillo, M., Coque, T. M., Valverde, A., Novais, A., Loza, E., Baquero, F. & Cantón, R. (2006). Antibiotic coresistance in extended-spectrum-β-lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline. Antimicrob Agents Chemother 50, 2695-2699.
20. Mulvey, M. R., Bryce, E., Boyd, D. A., Ofner-Agostini, M., Land, A. M., Simor, A. E. & Paton, S. (2005). Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian Hospitals. Antimicrob Agents Chemother 49, 358-365.
21. Nicolas-Chanoine, M. H., Blanco, J., Leflon-Guibout, V., Demarty, R., Alonso, M. P., Caniça, M. M., Park, Y. J., Lavigne, J. P., Pitout, J. & Johnson, J. R. (2008). Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 61, 273-281.
22. CTX-M-9 are linked to class 1 integrons containing CR1 associated with defective transposon derivatives from Tn402 located in early antibiotic resistance plasmids of IncH12, IncP1-α, and IncFI groups. Antimicrob Agents Chemother 50, 2741-2750.
23. Oliver, A., Coque, T. M., Alonso, D., Valverde, A., Baquero, F. & Cantón, R. (2005). CTX-M-10 linked to a phage-related element is widely disseminated among Enterobacteriaceae in a Spanish hospital. Antimicrob Agents Chemother 49, 1567-1571.
24. Paterson, D. L., Hujer, K. M., Hujer, A. M., Yeiser, B., Bonomo, M. D., Rice, L. B., Bonomo, R. A. & the International Klebsiella Study Group (2003). Extended-spectrum β-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type β-lactamases. Antimicrob Agents Chemother 47, 3554-3560.
25. Poirel, L., Naas, T. & Nordmann, P. (2008). Genetic support of extended-spectrum β- lactamases. Clin Microbiol Infect 14, 75-81.
26. Riaño, I., Moreno, M. A., Teshager, T., Sáenz, Y., Domínguez, L. & Torres, C. (2006). Detection and characterization of extended-spectrum β-lactamases in Salmonella enterica strains of healthy food animals in Spain. J Antimicrob Chemother 58, 844-847.
27. Rossolini, G. M., D'Andrea, M. M. & Mugnaioli, C. (2008). The spread of CTX-M-type extended-spectrum β-lactamases. Clin Microbiol Infect 14, 33-41.
28. CTX-M-9. Antimicrob Agents Chemother 46, 2656-2661.
29. Sáenz, Y., Briñas, L., Domínguez, E., Ruiz, J., Zarazaga, M., Vila, J. & Torres, C. (2004). Mechanisms of resistance in multiple-antibiotic-resistant Escherichia coli strains of human, animal, and food origins. Antimicrob Agents Chemother 48, 3996-4001.
30. Saladin, M., Cao, V. T. B., Lambert, T., Donay, J. L., Herrmann, J. L., Ould-Hocine, Z., Verdet, C., Delisle, F., Philippon, A. & Arlet, G. (2002). Diversity of CTX-M β-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiol Lett 209, 161-168.
31. Stapleton, P. D., Shannon, K. P. & French, G. L. (1999). Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 β-lactamase production and loss of an outer membrane protein. Antimicrob Agents Chemother 43, 1206-1210.
32. Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H. & Swaminathan, B. (1995). Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33, 2233-2239.
33. Valverde, A., Coque, T. M., Sánchez-Moreno, M. P., Rollán, A., Baquero, F. & Cantón, R. (2004). Dramatic increase in prevalence of fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol 42, 4769-4775.
34. Velasco, C., Romero, L., Martínez, J. M., Rodríguez- Baño, J. & Pascual, A. (2007). Analysis of plasmids encoding extended-spectrum β-lactamases (ESBLs) from Escherichia coli isolated from non-hospitalised patients in Seville. Int J Antimicrob Agents 29, 89-92.